| Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post–myocardial infarction mortality AT Yan, AJ Shayne, KA Brown, SN Gupta, CW Chan, TM Luu, MF Di Carli, ... Circulation 114 (1), 32-39, 2006 | 899 | 2006 |
| 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task … LD Hillis, PK Smith, JL Anderson, JA Bittl, CR Bridges, JG Byrne, ... Journal of the American College of Cardiology 58 (24), 2584-2614, 2011 | 675 | 2011 |
| Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium MW Irwin, S Mak, DL Mann, R Qu, JM Penninger, A Yan, F Dawood, ... Circulation 99 (11), 1492-1498, 1999 | 563 | 1999 |
| Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART CardioLink-6 randomized clinical trial S Verma, CD Mazer, AT Yan, T Mason, V Garg, H Teoh, F Zuo, A Quan, ... Circulation 140 (21), 1693-1702, 2019 | 561 | 2019 |
| Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better AT Yan, RT Yan, M Tan, A Casanova, M Labinaz, K Sridhar, DH Fitchett, ... European heart journal 28 (9), 1072-1078, 2007 | 363 | 2007 |
| Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes mellitus and coronary artery disease CD Mazer, GMT Hare, PW Connelly, RE Gilbert, N Shehata, A Quan, ... Circulation 141 (8), 704-707, 2020 | 334 | 2020 |
| Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study AT Yan, M Koh, KK Chan, H Guo, DA Alter, PC Austin, JV Tu, ... Journal of the American College of Cardiology 69 (12), 1523-1532, 2017 | 294 | 2017 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 293 | 2019 |
| Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada B Elbarouni, SG Goodman, RT Yan, RC Welsh, JM Kornder, JP DeYoung, ... American heart journal 158 (3), 392-399, 2009 | 287 | 2009 |
| The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes SG Goodman, W Huang, AT Yan, A Budaj, BM Kennelly, JM Gore, ... American heart journal 158 (2), 193-201. e5, 2009 | 281 | 2009 |
| Effect of empagliflozin on left ventricular mass and diastolic function in individuals with diabetes: an important clue to the EMPA-REG OUTCOME trial? S Verma, A Garg, AT Yan, AK Gupta, M Al-Omran, A Sabongui, H Teoh, ... Diabetes care 39 (12), e212-e213, 2016 | 270 | 2016 |
| Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes S Poon, SG Goodman, RT Yan, R Bugiardini, AS Bierman, KA Eagle, ... American heart journal 163 (1), 66-73, 2012 | 249 | 2012 |
| Factors influencing underutilization of evidence-based therapies in women R Bugiardini, AT Yan, RT Yan, D Fitchett, A Langer, O Manfrini, ... European heart journal 32 (11), 1337-1344, 2011 | 235 | 2011 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 212 | 2019 |
| Relationship of ST elevation in lead aVR with angiographic findings and outcome in non–ST elevation acute coronary syndromes AT Yan, RT Yan, BM Kennelly, FA Anderson Jr, A Budaj, J López-Sendón, ... American heart journal 154 (1), 71-78, 2007 | 188 | 2007 |
| Hybrid approach improves success of chronic total occlusion angioplasty WM Wilson, SJ Walsh, AT Yan, CG Hanratty, AJ Bagnall, M Egred, ... Heart 102 (18), 1486-1493, 2016 | 181 | 2016 |
| Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome AT Yan, RT Yan, M Tan, T Huynh, K Soghrati, LJ Brunner, P DeYoung, ... American heart journal 154 (6), 1108-1115, 2007 | 178 | 2007 |
| Management patterns in relation to risk stratification among patients with non–ST elevation acute coronary syndromes AT Yan, RT Yan, M Tan, A Fung, EA Cohen, DH Fitchett, A Langer, ... Archives of internal medicine 167 (10), 1009-1016, 2007 | 175 | 2007 |
| Chemotherapy-induced cardiotoxicity: detection, prevention, and management J Truong, AT Yan, G Cramarossa, KKW Chan Canadian Journal of Cardiology 30 (8), 869-878, 2014 | 170 | 2014 |
| Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry AT Yan, RT Yan, T Huynh, A Casanova, FE Raimondo, DH Fitchett, ... Archives of internal medicine 169 (4), 372-378, 2009 | 169 | 2009 |
